ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "cystic fibrosis transmembrane conductance regulator"
cystic fibrosis transmembrane conductance regulator
Publikace
Předměty
Osoby
Publikace
Studium
publication
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis
1996 |
Ústřední knihovna
publication
A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis
1998 |
Ústřední knihovna
publication
Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign
2004 |
2. lékařská fakulta
publication
Health-economic aspects of cystic fibrosis screening and therapy
2014 |
2. lékařská fakulta
publication
Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype
2004 |
2. lékařská fakulta
publication
Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels
2000 |
2. lékařská fakulta
publication
Elexakaftor: modulátor proteinu CFTR nové generace
2021 |
2. lékařská fakulta
publication
Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening
2002 |
2. lékařská fakulta
publication
Clinical Phenotype and Genotype of Children with Borderline Sweat Test and Abnormal Nasal Epithelial Chloride Transport
2010 |
2. lékařská fakulta
publication
Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA
2012 |
2. lékařská fakulta, Ústřední knihovna, 3. lékařská fakulta
publication
Case report of a Thai male cystic fibrosis patinet with the 1898+ 1G-->T splicing mutation in the CFTR gene: a review of East Asian cases. Mutations in brief no. 196. Online
1998 |
2. lékařská fakulta
publication
Možnosti léčby cystické fibrózy - 1. část
2007 |
2. lékařská fakulta
publication
Aktuální možnosti kauzální terapie cystické fibrózy v dětském věku
2021 |
Lékařská fakulta v Plzni
publication
Evaluation of High-Resolution Melting (HRM) for Mutation Scanning of Selected Exons of the CFTR Gene
2009 |
2. lékařská fakulta
publication
Farmakoterapie cystické fibrózy
2010 |
2. lékařská fakulta
publication
Frequency of the ΔF508 mutation and flanking marker haplotypes at the CF locus from 167 Czech families
1990 |
2. lékařská fakulta, Ústřední knihovna
publication
A large-scale study of the random variability of a coding sequence: a study on the CFTR gene
2005 |
2. lékařská fakulta
publication
Recommendations for the classification of diseases as CFTR-related disorders
2011 |
2. lékařská fakulta
publication
Terapeutické trendy cystické fibrózy
2014 |
2. lékařská fakulta
publication
Haplotype block structure study of the CFTR gene. Most variants are associated with the M470 allele in several European populations
2006 |
2. lékařská fakulta
publication
Pancreatic insufficiency and pulmonary disease in German and Slavic cystic fibrosis patients with the R347P mutation
1995 |
2. lékařská fakulta
publication
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 |
2. lékařská fakulta
publication
Současný pohled na diagnostiku a nové možnosti terapie cystické fibrózy
2016 |
Lékařská fakulta v Plzni
publication
Mutations in the Amiloride-Sensitive Epithelial Sodium Channel in Patients With Cystic Fibrosis-Like Disease
2009 |
2. lékařská fakulta
publication
Standards for the care of people with cystic fibrosis; establishing and maintaining health
2024 |
2. lékařská fakulta
publication
Complete Ascertainment of Intragenic Copy Number Mutations (CNMs) in the CFTR Gene and its Implications for CNM Formation at Other Autosomal Loci
2010 |
2. lékařská fakulta
publication
Cystic fibrosis patients bearing both the common missense mutation GlyRIGHTWARDS ARROWAsp at codon 551 and the ΔF508 mutation are clinically indistinguishable from ΔF508 homozygotes, except for decreased risk of meconium ileus
1992 |
2. lékařská fakulta
publication
Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis
2018 |
2. lékařská fakulta
publication
Cystic Fibrosis Revisited - a Review Study
2017 |
Publikace bez příslušnosti k fakultě
publication
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
2015 |
2. lékařská fakulta